You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LGND Sale Disclosure
Lamattina John L · SEC Form 4 · Filed Jun 12, 2026
Sale
Calculated transaction value
$63.54K
Lamattina John L Director
LGND
Transaction date
Jun 10, 2026
Public filing date
Jun 12, 2026
Filing lag
Filed 2 days later
LGND daily price context
Close on/before transaction
$248.24
Jun 10, 2026
First close after public filing
$253.25
Jun 15, 2026
30-day return after filing
+22.11%
Through Jul 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 257 shares @ $247.22
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002001011-26-000102
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$1.15M
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND Current | Sale | Jun 10, 2026 | $63.54K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 10, 2026 | $57.56K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 10, 2026 | $173.92K |
| Ligand Pharmaceuticals Inc LGND | Sale | Jun 10, 2026 | $856.75K |